Wendy K.D. Selig is President and CEO of the Melanoma Research Alliance (MRA), a public charity focused on finding and funding the most promising melanoma research worldwide to accelerate progress toward a cure. Ms. Selig drives and manages MRA’s strategic priorities, research portfolio, and day?to?day operations. Under her leadership, MRA is accelerating progress toward a cure for melanoma by supporting an international, cross?disciplinary group of biomedical researchers exploring, identifying, and pursuing innovative, transformative research.
Prior to joining the MRA, Ms. Selig spent nearly a decade in leadership positions at the American Cancer Society and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN). She currently chairs the Board of Directors of the National Coalition of Cancer Research (NCCR), and is a member of the Government Affairs Committee of the
Prostate Cancer Foundation (PCF), and the Patient Leadership Council (PLC) of the Clinical Trials Transformation Initiative (CTTI). She previously served as Chair of the United for Medical research (UMR) coalition and a member of the Directors Consumer Liaison Group (DCLG) at the National Cancer Institute (NCI). From 1989?2000, Ms. Selig served on Capitol Hill as a top aide for U.S. Representative Porter J. Goss (R?FL), the House Rules Committee and the House Permanent Select Committee on Intelligence (HPSCI). Ms. Selig is a Magna Cum Laude graduate of Princeton University and holds a Masters in Science from Northwestern University’s Medill School of Journalism.